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Many functions of monocyte/macrophage nd granulocyte are activated by tuftsin; principally phagocyto- 
sis, motility, immunogenic stimulation, antibacterial nd antineoplastic a tivities. Here it is shown that 
tuftsin stimulates HL60 growth to twice the control rate. The uptake of PH]uridine and PH]leucine in a 
pulse of 30 min was also double that of the control. The uptake of thymidine was not stimulated. 
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1. INTRODUCTION 
Tuftsin (Thr-Lys-ProArg) was discovered in 
this laboratory several years ago [l-3]. It is a 
highly active tetrapeptide that activates phagocytic 
cells [4]. It is a part of a carrier molecule, a 
leukophilic y-globulin that binds specifically to 
PMN and macrophage/monocyte cells [5-71. It is 
active only as the free tetrapeptide. Consequently, 
it requires two enzymes to cleave it off the carrier 
molecule [l-4]; a splenic enzyme, tuftsin- 
endocarboxypeptidase and a cell membrane en- 
zyme leukokininase. The latter-is present on the 
outer surface of the membrane and is active in the 
intact viable cell, as well as in broken cell mem- 
branes. In instances where the spleen is removed, 
the tetrapeptide remains covalently anchored at the 
arginine carboxy-end, and as such is inactive. Such 
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a state of affairs results in an ‘acquired tuftsin’ 
deficiency with its attendant severe infections 
[8,9]. We have also discovered another type of 
deficiency ‘congenital familial tuftsin deficiency’ 
[lO,l l] in which the active tetrapeptide tuftsin, 
Thr-Lys-Pro-Arg, is replaced by the inactive and 
inhibitory tetrapeptide, Thr-Glu-Pro-Arg. Here a 
transition mutation, A-G, results in the replace- 
ment of lysine with the glutamate residue in either 
of the two lysine triplets. We have identified 17 pa- 
tients with this deficiency and 2 were described in 
Japan [ 121. All showed repeated severe infections. 
The presence of this mutation renders tuftsin a true 
biological entity with a defined physiological 
function. 
The activation of phagocytic cells, macro- 
phage/monocyte, and PMN by tuftsin results in 
the stimulation of phagocytosis [l-3], motility [3], 
immunogenic response [ 131, reversal of age 
depressed activities [ 14,151, bactericidal [ 161 and 
tumoricidal activities [17]. Specific tuftsin recep- 
tors are found on phagocytic cells. We have 
purified them to apparent homogeneity from rab- 
bit peritoneal granulocytes [ 171. They are com- 
posed of two subunits, an ff of 62 kDa and a p 
52 kDa subunit. Similarly, receptors on HL60 
cells, a promyelocytic human cell line, showed an 
a-subunit of mass 67 kDa and a P-subunit of 
55 kDa [18]. 
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From the standpoint of lethal effects of the 
phagocyte on target cells, both mammalian and 
bacterial, we have shown substantial tuftsin 
stimulation of the formation of tumor necrosis 
factor, cachectin, in mice both in vitro and in vivo, 
as well as in the cell line HL60 [19]. Similarly, the 
large tuftsin stimulation of the superoxide anion 
and hydrogen peroxide formation [20,21] may well 
add to the lethal effects of the phagocytic cell. 
Because of the increased and varied biological 
expressions of phagocytic cells upon activation by 
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Fig.1. HL60 cells were grown in a basal medium 
consisting of RPM1 1640, 2 mM glutamine, 100 U 
penicillin and 1OOpg of streptomycin/ml in 5% CO2 at 
37°C with added 10% FCS. Cells were washed with 
basal medium without FCS and allowed to equilibrate 
for 1 h at 37°C. To a sample containing4 x lo5 cells/ml, 
tuftsin (t) was added to 0.1 fig/ml. Control (c) received 
no tuftsin. After 1 h of tuftsin activation at 37”C, 1 ml 
of (c) cells and 1 ml of (t) cells were transferred each to 
a separate falcon dish 35 x 100 mm containing 10 ,uCi 
[3H]leucine (Leu). A similar dish was prepared 
containing in addition 6pM cycloheximide as inhibitor 
of leucine incorporation. After 30 min incubation, 
dishes were washed in cold PBS and washed twice in 7% 
trichloroacetic acid. Pellet was dissolved in 0.1 N NaOH 
and counted. The method used for the incorporation 
from 10&i [3H]thymidine (T), 10&i [3H]uridine (U) 
was exactly as for leucine except for the use of 6pM 
actinomycin D and mitomycin as inhibitors of thymidine 
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Fig.2. All growth experiments were done in RPM1 1640 
complete medium as in fig. 1, but with added 10% FCS. 
Aliquots of growing cells usually around 1 x lo’, were 
transferred into flasks containing 100 ml of complete 
medium with and without tuftsin (t) 1 bug/ml. Since 
tuftsin is unstable in serum [26], it was added once daily 
to obtain a fresh concentration of 1 pg/ml. Flasks were 
incubated at 37°C in 5% CO2. The pH was maintained 
by the addition of the necessary amount of fresh 
medium. All cells were counted each day. The number of 
and uridine incorporation, respectively. cells are plotted against days of incubation. 
tuftsin, it became of interest to determine whether 
tuftsin has any effect on cell growth in complete 
RPM1 1640 medium with added FCS. Of equal in- 
terest is the possible stimulation of the rate of in- 
corporation, during a short pulse, of labeled 
thymidine, uridine and leucine into DNA, RNA 
and protein, respectively, in the absence of growth, 
in RPM1 lacking FCS. 
This article shows that indeed the stimulation of 
the rate of growth of HL60 cells by 1 pg/ml of 
tuftsin and the stimulation of uridine and leucine 
incorporation by 0.1 pg/ml was substantial. 
2. MATERIALS AND METHODS 
HL60 human cell line (ATCC, Rockville, MD); 
RPM1 1640 culture medium (Tufts University 
School of Medicine, Boston, MA); FCS (Hy-Clone 
1 - 
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Laboratories, Logan, UT); [3H]thymidine (25 Ci/ 
mmol), [3H]uridine (50 Ci/mmol), [3H]leucine 
(50 Ci/mmol) (Amersham, Arlington Heights, 
IL); mitomycin, actinomycin D and cycloheximide 
(Sigma, St. Louis, MO); glutamine, penicillin and 
streptomycin (Irvine Scientific, Santa Ana, CA). 
Tuftsin was synthesized by the solid-phase 
method [22] and the use of TFMS for deblocking 
[23] protective groups, and in addition cleavage of 
the arginyl-resin bond [24]. 
3. RESULTS AND DISCUSSION 
Fig.1 illustrates the results obtained in over 10 
experiments. In each case, washed cells were 
equilibrated in RPM1 1640 for 1 h without FCS. 
Following this, a 30 min pulse was performed with 
10&i each of [3H]thymidine, [3H]uridine and 
[3H]leucine in the presence and absence of 0.1 pg 
tuftsin/ml. This resulted in a substantial and 
reproducible tuftsin stimulation of incorporation 
of both [3H]uridine and [3H]leucine. However, 
[3H]thymidine in this FCS-deficient medium 
showed no increased incorporation. This was ex- 
pected as no growth occurs in the absence of FCS 
[25]. The presence of specific inhibitors for DNA, 
RNA and protein showed almost complete inhibi- 
tion of incorporation. 
Growth experiments with HL60 in RPM1 1640 
with 10% FCS were carried out with and without 
1 .O pg/ml of tuftsin. They were allowed to grow at 
37°C in 5% CO2 in air and an aliquot counted 
every 24 h. The pH was maintained by the addition 
of fresh medium. Because of the instability of tuft- 
sin in the presence of serum, fresh tuftsin was add- 
ed each day to replenish the level of 1 fig/ml of 
culture medium [26]. 
Fig.2 illustrates the growth in the absence and 
presence of tuftsin. The stimulation of growth of 
HL60 cells, in an otherwise complete medium [25], 
was particularly pronounced during the first 24 h 
of growth. It is possible that this is due to the inter- 
nalization of the receptors following exposure to 
tuftsin; a process of down-regulation. The genera- 
tion time of HL60 cells in this complete medium is 
approx. 24 h [27]. In the presence of tuftsin this 
was considerably reduced. 
The mechanism of stimulation of growth by 
tuftsin is unknown. However, the stimulation of 
pinocytic activity by tuftsin [2,3] should be con- 
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sidered in that it may result in an increase in 
nutrient uptake that might influence the rate of 
growth, if indeed this is a rate limiting step. This 
does not seem to be a likely possibility. 
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